Drug Patents owned by Metuchen Pharms
1. Drug name - STENDRA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6656935 | METUCHEN PHARMS | Aromatic nitrogen-containing 6-membered cyclic compounds |
Apr, 2025
(2 years from now) | |
| CN1440393A | METUCHEN PHARMS | Cyclic Compound |
Sep, 2009
(13 years ago) | |
| CN1657523A | METUCHEN PHARMS | Cyclic Compound |
Dec, 2009
(12 years ago) | |
| IN200200391P4 | METUCHEN PHARMS | Aromatic Nitrogen-Containing 6-Membered Cyclic Compounds |
Sep, 2020
(2 years ago) | |
| IN225614B | METUCHEN PHARMS | Aromatic Nitrogen-Containing 6-Membered Cyclic Compounds |
Sep, 2020
(2 years ago) | |
| EP1219609B1 | METUCHEN PHARMS | Aromatic Nitrogenous Six-Membered Ring Compounds |
Sep, 2025
(2 years from now) | |
| EP1219609A1 | METUCHEN PHARMS | Aromatic Nitrogenous Six-Membered Ring Compounds |
Sep, 2025
(2 years from now) | |
| EP1219609A4 | METUCHEN PHARMS | Aromatic Nitrogenous Six-Membered Ring Compounds |
Sep, 2025
(2 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7501409 | METUCHEN PHARMS | Preparations for oral administration |
May, 2023
(7 months from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 50MG | TABLET;ORAL | Prescription |
| 100MG | TABLET;ORAL | Prescription |
| 200MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.